Loading...
Kyowa Kirin Co., Ltd.
4151.T•JPX
HealthcareDrug Manufacturers - General
¥2434.00
¥-31.00(-1.26%)
Kyowa Kirin Co., Ltd. (4151.T) Financial Performance & Statements
Review Kyowa Kirin Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
12.06%
↑ 12.06%
Operating Income Growth
-4.15%
↓ 4.15%
Net Income Growth
-26.26%
↓ 26.26%
Operating Cash Flow Growth
-41.25%
↓ 41.25%
Operating Margin
17.16%
↑ 17.16%
Gross Margin
72.79%
↑ 72.79%
Net Profit Margin
10.39%
↑ 10.39%
ROE
6.08%
↑ 6.08%
ROIC
9.65%
↑ 9.65%
Kyowa Kirin Co., Ltd. (4151.T) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Kyowa Kirin Co., Ltd. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $132.76B | $129.82B | $127.40B | $105.57B |
| Cost of Revenue | $38.60B | $34.54B | $36.88B | $28.57B |
| Gross Profit | $94.16B | $95.28B | $90.53B | $77.00B |
| Gross Profit Ratio | $0.71 | $0.73 | $0.71 | $0.73 |
| R&D Expenses | $29.25B | $25.05B | $25.93B | $23.32B |
| SG&A Expenses | $43.92B | $40.38B | $40.07B | $37.19B |
| Operating Expenses | $73.17B | $65.43B | $66.00B | $60.50B |
| Total Costs & Expenses | $111.78B | $99.97B | $102.87B | $89.08B |
| Interest Income | $0.00 | $0.00 | $2.54B | $1.02B |
| Interest Expense | $0.00 | $979.00M | $729.00M | $188.00M |
| Depreciation & Amortization | $5.98B | $6.73B | $6.47B | $5.61B |
| EBITDA | $26.97B | $32.33B | $30.87B | $21.97B |
| EBITDA Ratio | $0.20 | $0.25 | $0.24 | $0.21 |
| Operating Income | $20.98B | $29.85B | $24.53B | $16.49B |
| Operating Income Ratio | $0.16 | $0.23 | $0.19 | $0.16 |
| Other Income/Expenses (Net) | -$9.10B | -$5.23B | $1.68B | $704.00M |
| Income Before Tax | $11.88B | $24.63B | $26.21B | $17.20B |
| Income Before Tax Ratio | $0.09 | $0.19 | $0.21 | $0.16 |
| Income Tax Expense | $7.91B | $6.93B | $5.28B | $3.47B |
| Net Income | $3.97B | $18.12B | $23.14B | $14.63B |
| Net Income Ratio | $0.03 | $0.14 | $0.18 | $0.14 |
| EPS | $7.57 | $34.44 | $43.56 | $27.26 |
| Diluted EPS | $7.57 | $34.43 | $43.55 | $27.26 |
| Weighted Avg Shares Outstanding | $523.97M | $526.25M | $531.37M | $536.68M |
| Weighted Avg Shares Outstanding (Diluted) | $523.97M | $526.33M | $531.40M | $536.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan